Sadberk L. Tokgozoglu

Ankara, 06230, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Influence of Mitral Annular Calcification Assessed by Cardiac Computed Tomography on Procedural and Clinical Outcomes of Transcatheter Aortic Valve Implantation.

Influence of Mitral Annular Calcification Assessed by Cardiac Computed Tomography on Procedural and Clinical Outcomes of Transcatheter Aortic Valve Implantation.

Journal: Medicina (Kaunas, Lithuania)

Published: April 24, 2026

Safety of low lipoprotein(a) levels: the FOURIER trial.

Safety of low lipoprotein(a) levels: the FOURIER trial.

Journal: European heart journal

Published: November 05, 2025

Pulmonary hypertension in Behçet's disease: echocardiographic screening and multidisciplinary approach.

Pulmonary hypertension in Behçet's disease: echocardiographic screening and multidisciplinary approach.

Journal: Turkish journal of medical sciences

Published: June 29, 2022

Breast artery calcification as an opportunistic predictor of cardiovascular disease.

Breast artery calcification as an opportunistic predictor of cardiovascular disease.

Journal: Irish journal of medical science

Published: May 02, 2022

Role of echocardiography on early diagnosis of atrial remodelling and fibrosis in elite athletes.

Role of echocardiography on early diagnosis of atrial remodelling and fibrosis in elite athletes.

Journal: The international journal of cardiovascular imaging

Published: March 13, 2022

JCL Roundtable: Global Think Tank on Lipoprotein(a).

JCL Roundtable: Global Think Tank on Lipoprotein(a).

Journal: Journal of clinical lipidology

Published: June 19, 2021

An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial.

An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial.

Journal: JAMA cardiology

Published: April 30, 2020

Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk.

Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk.

Journal: Circulation

Published: December 28, 2018

Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial.

Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial.

Journal: JAMA cardiology

Published: November 09, 2017

Serum PON-1 activity but not Q192R polymorphism is related to the extent of atherosclerosis.

Serum PON-1 activity but not Q192R polymorphism is related to the extent of atherosclerosis.

Journal: Journal of atherosclerosis and thrombosis

Published: December 23, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026